Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Azenta -- Ignore unavailable to you. Want to Upgrade?

To: robert b furman who wrote (1094)	12/6/2020 9:51:06 AM
From: robert b furman	Read Replies (1) \| Respond to of 1138

It appears that Brooks is one company that has found its life sciences division to be in the sweet spot with this Covid pandemic happening. Their web sight now has an area devoted to Vaccine handling procedures, including Vaccine cryopod carrier: brookslifesciences.com I have sold of 7500 shares of Brooks at an average of 68.15 and sold calls on another 7500 shares. If the calls deliver my stock, I'll average exactly. $70.00 on 15,000 shares. At this point my original investment is recovered, the calls will help pay the taxes and give me a substantial profit. I'll keep my remaining position, hoping for a hail mary on this dynamic company! GULP! Bob